BrainStorm Cell Therapeutics
BCLI
#10936
Rank
C$14.95 M
Marketcap
C$1.35
Share price
6.67%
Change (1 day)
48.43%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): C-$0.80

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.51. In 2022 the company made an earnings per share (EPS) of C-$0.93 an increase over its 2021 EPS that were of C-$0.96.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$0.80-14.16%
2022C-$0.93-2.94%
2021C-$0.96-37.04%
2020C-$1.521.89%
2019C-$1.5051.43%
2018C-$0.99159.26%
2017C-$0.38-3.57%
2016C-$0.40-37.78%
2015C-$0.64-33.82%
2014C-$0.9636%
2013C-$0.7111.11%
2012C-$0.6450%
2011C-$0.42-50%
2010C-$0.85-233.33%
2009C$0.64-142.86%
2008C-$1.48-65%
2007C-$4.23
2005C$1.40-108.03%
2004C-$17.4113203.07%
2003C-$0.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
C$3.33-320.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C-$4.38 189.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
C-$5.66 274.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C-$10.19 574.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$2.85-288.79%๐Ÿ‡บ๐Ÿ‡ธ USA